X0609 4 2025-03-07 0001398733 Aquestive Therapeutics, Inc. AQST 0001280273 TOTH A ERNEST JR false C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE WARREN NJ 07059 false true false false SVP, Chief Financial Officer 0 Performance Stock Units 2025-03-07 4 A false 82500 0 A 2028-03-07 Common Stock 82500 82500 D This Form 4 was filed late due to an inadvertent administrative oversight. Each PSU represents a contingent right to receive one share of the Company's common stock. The PSUs measure performance from March 7, 2025 (Grant Date) through March 7, 2028 and, if earned, vest 100% on March 7, 2028. "Performance Price" means (i) the 30-day average Nasdaq closing price ending on the last day of the period from the Grant Date through the day before the second anniversary (First Pricing Period) and (ii) the highest 30-day average Nasdaq closing price during the period from the second through the third anniversary (Second Pricing Period). /s/ Lori Braender, as Attorney-In-Fact 2026-04-13